NCT05359159

Brief Summary

People affected by SARS-CoV-2 infection, whether patients have developed mild forms or a severe form of the disease, complain of nonspecific and entirely new symptoms or complain about the persistence pf them.Investigators intend to follow over time the post-infectious phase of patients discharged from sub-intensive care unit. The aim is to identify symptoms and their frequency of presentation in the SARS-CoV-2 population in the post-acute period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 27, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 3, 2022

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

December 5, 2023

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

April 27, 2022

Last Update Submit

November 28, 2023

Conditions

Keywords

Long-COVIDpost-COVIDSarS-CoV2

Outcome Measures

Primary Outcomes (1)

  • Greater understanding of SARS-CoV-2 disease

    Greater understanding of SARS-CoV-2 disease and its long-term manifestations. To this end, the clinical manifestations, any alterations in laboratory and instrumental parameters will be evaluated to identify organ damages and calculate its prevalence

    24 months

Secondary Outcomes (1)

  • Measurement of psychological impact of SARS-CoV-2 disease

    24 months

Study Arms (2)

Post-COVID patients

Patients recovered from Sars-CoV2 infection

Other: Data collection

healthy control patients

Patients who did not have Sars-CoV2

Other: Data collection

Interventions

Data collection

Post-COVID patientshealthy control patients

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients admitted to Ospedale San Salvatore dell'Aquila over 18 years during Sars-CoV2 pandemics, with or without Sars-CoV2 related disease

You may qualify if:

  • Patients over 18

You may not qualify if:

  • Patients under 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clara Balsano

L’Aquila, Italy/L'Aquila, 67100, Italy

RECRUITING

University of L'Aquila

L’Aquila, 67100, Italy

RECRUITING

MeSH Terms

Conditions

COVID-19Post-Acute COVID-19 Syndrome

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full professor

Study Record Dates

First Submitted

April 27, 2022

First Posted

May 3, 2022

Study Start

February 1, 2021

Primary Completion

February 1, 2022

Study Completion

February 1, 2024

Last Updated

December 5, 2023

Record last verified: 2023-11

Locations